Consultants in RHeumatology

We are looking to appoint 2 full time Consultant Rheumatologists to join our enthusiastic multidisciplinary team at the Sandwell and West Birmingham NHS Trust. These 2 vacancies are replacement posts.

The post holders will join the existing team of Rheumatology at City and/or Sandwell Hospital and provide in-patient support at the eagerly anticipated brand new Midland Metropolitan University Hospital when it opens in 2024

The opening of the new Midland Metropolitan Hospital in 2024 and system working across the ICS and with local partners offers fantastic opportunities to improve rheumatological care, research and training in Birmingham and the Black Country. Why wouldn’t you want to be part of that aspiration?

Clinical Duties

This includes direct clinical carewith outpatient activity, day case provision, multi-disciplinary meetings, clinical administration related to the above and management of in-patient and ward referrals. These will be delivered as part of the wider MDT across any of our sites.

On call commitments

The on call commitment for this post is a non-resident telephone advisory service covering the Sandwell and the City hospital sites outside of working hours including weekends. This is currently a 1 in 8 rota frequency that is remunerated according to category B (2%).

Duties other than those specified will be in accordance with the Job Plan to be agreed with the appointee, the Clinical Director and the Group director and will allow time for administration, teaching, research, clinical audit and Continued Professional Development. A mentor and development support will be provided to the appointees based on personal and service needs at the Trust.

Sandwell and West Birmingham NHS Trust (SWBT) is an integrated care organisation with a budget of approximately £600 million and over 7,000 staff. Diversity and social care is at the core of what we do as the Trust provides Community and Acute Services to over half a million people in an urban centre that demands massive regeneration and has substantial premature mortality.

**We have three newly emerging strategic objectives**:
1. Our People - to cultivate and sustain happy, productive and engaged staff
2. Our Patients - to be good or outstanding in everything we do

3.Our Population - to work seamlessly with our partners to improve lives

We run services from Sandwell, City and Rowley Regis Hospitals, Birmingham & Midland Eye Centre, Birmingham Treatment Centre, the Lyng and Leasowes Intermediate Care Centre. Our GP practices and community teams provide care in schools, healthcare centres and at home.

Our next milestone is opening the Midland Metropolitan University Hospital (MMUH), a once in a career opportunity to shape care transformation within and beyond the hospital walls. MMUH will host the busiest Emergency Department in Europe, with state of the art facilities and future development of a Learning Campus.

Developing and caring for our People is fundamental. We were one of the first Trusts to provide the Real Living Wage, as well as a Live and Work scheme to support people at risk of homelessness into paid work and training. We offer a range of staff benefits, health & wellbeing support and will help you to bring your ambition to life through our bespoke training and development programmes. As “People” is one of our three strategic objectives, we make a continued commitment to prioritise support for all our colleagues.

Information about the Specialty

The Rheumatology Department has a long-established track record of excellence in research, teaching and training. SWBH is nationally recognized for delivering Specialized Rheumatology services including Behçet’s Disease, Systemic Vasculitis, Lupus, and Myositis a. SWBH also works with Birmingham Women’s Hospital to deliver pre-pregnancy and antenatal clinics at regional level.

Birmingham, with Oxford, Newcastle and Glasgow is part of the Versus Arthritis funded Centre of Excellence in Inflammatory Arthritis and as part of this we run a large portfolio of research studies in inflammatory arthritis including discovery science, experimental medicine and clinical trials. We have an active portfolio of lupus research including national and international studies, including experimental and clinical studies. We are actively investigating the natural history of SLE, response to biological therapies and cutaneous lupus. In terms of our interdisciplinary national centre of excellence for Behçet’s, there is ongoing grant funded research examining the national epidemiology and outcomes of Behçet’s and a programme of clinical research including the recently completed UK bio-Behçet’s trial.

Depending on the interests of the appointee, the post holder will be supported to develop in a number of areas where we have existing strength such as early inflammatory arthritis, osteoporosis, Vasculitis, Behçet’s disease, and SLE, in addition to teaching and research.

For more infor